|Articles|January 5, 2022

SMFM provides update on provider considerations for engaging in COVID-19 vaccine counseling with pregnant, lactating patients

Author(s)The Society for Maternal-Fetal Medicine (SMFM)

The Society for Maternal-Fetal Medicine has published an update for provider considerations for COVID-19 vaccine counseling with pregnant or lactating patients.

Click the image to read the full guidance.

SMFM: Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Prenatal COVID-19 exposure linked to adverse offspring neurodevelopment

ByCeleste Krewson, Assistant Editor

November 6th 2025

Mikael Björnson, MD, links long COVID and POTS

ByMikael Björnson, MD

October 27th 2025

Birth defect risk not impacted by COVID-19 vaccination

ByCeleste Krewson, Assistant Editor

October 18th 2025

Contemporary OB/GYN week in review: birth complications, fasting, and more

ByCeleste Krewson, Assistant Editor

October 17th 2025

POTS common among women with long COVID

ByCeleste Krewson, Assistant Editor

October 13th 2025

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

SMFM provides update on provider considerations for engaging in COVID-19 vaccine counseling with pregnant, lactating patients

Newsletter

Related Content

Prenatal COVID-19 exposure linked to adverse offspring neurodevelopment

Mikael Björnson, MD, links long COVID and POTS

Birth defect risk not impacted by COVID-19 vaccination

Contemporary OB/GYN week in review: birth complications, fasting, and more

POTS common among women with long COVID

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

High costs and transfusions linked to acute heavy menstrual bleeding

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more